Literature DB >> 10886313

Unexpectedly severe sleep and respiratory pathology in patients with amyotrophic lateral sclerosis.

G M Barthlen1, D J Lange.   

Abstract

Daytime fatigue and sleep disturbance are frequent complaints in patients with amyotrophic lateral sclerosis (ALS). However, polysomnographic data are sparse. Nocturnal respiratory insufficiency may occur despite nearly normal daytime pulmonary function. We describe the clinical presentation and polysomnographic findings in two patients with clinically and electrophysiologically confirmed ALS with minimal weakness but excessive daytime sleepiness. Polysomnography in the first patient showed a respiratory disturbance index of 43.5, and profound oxygen desaturations to 62%. The second patient had prolonged periods of hypoventilation, with oxygen saturations oscillating between 86 and 83%. Both patients showed severe sleep maintenance insomnia with a sleep efficiency < 40% and frequent arousals while asleep. Application of continuous positive airway pressure (CPAP) restored normal nocturnal ventilation, blood oxygenation and sleep parameters in the first patient; compliance, however, was poor. The second patient was unable to tolerate CPAP. We conclude that ALS patients with excessive daytime sleepiness or insomnia should undergo polysomnography to adequately diagnose nocturnal respiratory insufficiency and sleep disturbance. Compliance with treatment, however, may be poor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886313     DOI: 10.1046/j.1468-1331.2000.00044.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  17 in total

Review 1.  Looking for inspiration: new perspectives on respiratory rhythm.

Authors:  Jack L Feldman; Christopher A Del Negro
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

Review 2.  A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions.

Authors:  Amy M Sawyer; Nalaka S Gooneratne; Carole L Marcus; Dafna Ofer; Kathy C Richards; Terri E Weaver
Journal:  Sleep Med Rev       Date:  2011-06-08       Impact factor: 11.609

3.  [Sleep in neurodegenerative disorders].

Authors:  S Happe; G Mayer
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

4.  Effects of noninvasive ventilation on sleep outcomes in amyotrophic lateral sclerosis.

Authors:  Hans D Katzberg; Adam Selegiman; Lee Guion; Nancy Yuan; Sungho C Cho; Jonathan S Katz; Robert G Miller; Yuen T So
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

5.  Changes in tongue pressure, pulmonary function, and salivary flow in patients with amyotrophic lateral sclerosis.

Authors:  Caryn Easterling; Jodi Antinoja; Susan Cashin; Paul E Barkhaus
Journal:  Dysphagia       Date:  2012-12-15       Impact factor: 3.438

Review 6.  Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.

Authors:  Svenja Happe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  The influence of psychological state and motivation on brain-computer interface performance in patients with amyotrophic lateral sclerosis - a longitudinal study.

Authors:  Femke Nijboer; Niels Birbaumer; Andrea Kübler
Journal:  Front Neurosci       Date:  2010-07-21       Impact factor: 4.677

8.  Evaluating the treatment of obstructive sleep apnea comorbid with insomnia disorder using an incomplete factorial design.

Authors:  Megan R Crawford; Arlener D Turner; James K Wyatt; Louis F Fogg; Jason C Ong
Journal:  Contemp Clin Trials       Date:  2015-12-28       Impact factor: 2.226

9.  Unilateral ablation of pre-Botzinger complex disrupts breathing during sleep but not wakefulness.

Authors:  Leanne C McKay; Jack L Feldman
Journal:  Am J Respir Crit Care Med       Date:  2008-04-17       Impact factor: 21.405

10.  Effect of fluoxetine on disease progression in a mouse model of ALS.

Authors:  J E Koschnitzky; K A Quinlan; T J Lukas; E Kajtaz; E J Kocevar; W F Mayers; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.